Copyright Reports & Markets. All rights reserved.

Global Ropivacaine Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Ropivacaine Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 2 mg/mL (0.2%)
    • 1.3.3 5 mg/mL (0.5%)
    • 1.3.4 7.5 mg/mL (0.75%)
    • 1.3.5 10 mg/mL (1%)
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Ropivacaine Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Surgical Anesthesia
    • 1.4.3 Major Nerve Block
    • 1.4.4 Acute Pain Management
    • 1.4.5 Other
  • 1.5 Global Ropivacaine Injection Market Size & Forecast
    • 1.5.1 Global Ropivacaine Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Ropivacaine Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Ropivacaine Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Pfizer
    • 2.1.1 Pfizer Details
    • 2.1.2 Pfizer Major Business
    • 2.1.3 Pfizer Ropivacaine Injection Product and Services
    • 2.1.4 Pfizer Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Pfizer Recent Developments/Updates
  • 2.2 Akorn
    • 2.2.1 Akorn Details
    • 2.2.2 Akorn Major Business
    • 2.2.3 Akorn Ropivacaine Injection Product and Services
    • 2.2.4 Akorn Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Akorn Recent Developments/Updates
  • 2.3 Anant Pharmaceuticals
    • 2.3.1 Anant Pharmaceuticals Details
    • 2.3.2 Anant Pharmaceuticals Major Business
    • 2.3.3 Anant Pharmaceuticals Ropivacaine Injection Product and Services
    • 2.3.4 Anant Pharmaceuticals Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Anant Pharmaceuticals Recent Developments/Updates
  • 2.4 SGPharma
    • 2.4.1 SGPharma Details
    • 2.4.2 SGPharma Major Business
    • 2.4.3 SGPharma Ropivacaine Injection Product and Services
    • 2.4.4 SGPharma Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 SGPharma Recent Developments/Updates
  • 2.5 Nephron Pharmaceuticals
    • 2.5.1 Nephron Pharmaceuticals Details
    • 2.5.2 Nephron Pharmaceuticals Major Business
    • 2.5.3 Nephron Pharmaceuticals Ropivacaine Injection Product and Services
    • 2.5.4 Nephron Pharmaceuticals Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Nephron Pharmaceuticals Recent Developments/Updates
  • 2.6 Sintetica SA
    • 2.6.1 Sintetica SA Details
    • 2.6.2 Sintetica SA Major Business
    • 2.6.3 Sintetica SA Ropivacaine Injection Product and Services
    • 2.6.4 Sintetica SA Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Sintetica SA Recent Developments/Updates
  • 2.7 AstraZeneca
    • 2.7.1 AstraZeneca Details
    • 2.7.2 AstraZeneca Major Business
    • 2.7.3 AstraZeneca Ropivacaine Injection Product and Services
    • 2.7.4 AstraZeneca Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 AstraZeneca Recent Developments/Updates
  • 2.8 Manus Aktteva Biopharma LLP
    • 2.8.1 Manus Aktteva Biopharma LLP Details
    • 2.8.2 Manus Aktteva Biopharma LLP Major Business
    • 2.8.3 Manus Aktteva Biopharma LLP Ropivacaine Injection Product and Services
    • 2.8.4 Manus Aktteva Biopharma LLP Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Manus Aktteva Biopharma LLP Recent Developments/Updates
  • 2.9 Zhejiang Xianju Pharmaceutical Co.,Ltd
    • 2.9.1 Zhejiang Xianju Pharmaceutical Co.,Ltd Details
    • 2.9.2 Zhejiang Xianju Pharmaceutical Co.,Ltd Major Business
    • 2.9.3 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
    • 2.9.4 Zhejiang Xianju Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Zhejiang Xianju Pharmaceutical Co.,Ltd Recent Developments/Updates
  • 2.10 Jiangsu Nhwa Pharmaceutical Co.,Ltd.
    • 2.10.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Details
    • 2.10.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Major Business
    • 2.10.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Product and Services
    • 2.10.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd. Recent Developments/Updates
  • 2.11 Yangzi River Pharmaceutical Group
    • 2.11.1 Yangzi River Pharmaceutical Group Details
    • 2.11.2 Yangzi River Pharmaceutical Group Major Business
    • 2.11.3 Yangzi River Pharmaceutical Group Ropivacaine Injection Product and Services
    • 2.11.4 Yangzi River Pharmaceutical Group Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Yangzi River Pharmaceutical Group Recent Developments/Updates
  • 2.12 Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    • 2.12.1 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Details
    • 2.12.2 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Major Business
    • 2.12.3 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Product and Services
    • 2.12.4 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Recent Developments/Updates
  • 2.13 Jiangsu Nhwa Pharmaceutical Co.,Ltd
    • 2.13.1 Jiangsu Nhwa Pharmaceutical Co.,Ltd Details
    • 2.13.2 Jiangsu Nhwa Pharmaceutical Co.,Ltd Major Business
    • 2.13.3 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Product and Services
    • 2.13.4 Jiangsu Nhwa Pharmaceutical Co.,Ltd Ropivacaine Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Jiangsu Nhwa Pharmaceutical Co.,Ltd Recent Developments/Updates

3 Competitive Environment: Ropivacaine Injection by Manufacturer

  • 3.1 Global Ropivacaine Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Ropivacaine Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Ropivacaine Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Ropivacaine Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Ropivacaine Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Ropivacaine Injection Manufacturer Market Share in 2025
  • 3.5 Ropivacaine Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Ropivacaine Injection Market: Region Footprint
    • 3.5.2 Ropivacaine Injection Market: Company Product Type Footprint
    • 3.5.3 Ropivacaine Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Ropivacaine Injection Market Size by Region
    • 4.1.1 Global Ropivacaine Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Ropivacaine Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Ropivacaine Injection Average Price by Region (2021-2032)
  • 4.2 North America Ropivacaine Injection Consumption Value (2021-2032)
  • 4.3 Europe Ropivacaine Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Ropivacaine Injection Consumption Value (2021-2032)
  • 4.5 South America Ropivacaine Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Ropivacaine Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Ropivacaine Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Ropivacaine Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Ropivacaine Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Ropivacaine Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Ropivacaine Injection Market Size by Country
    • 7.3.1 North America Ropivacaine Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Ropivacaine Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Ropivacaine Injection Market Size by Country
    • 8.3.1 Europe Ropivacaine Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Ropivacaine Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Ropivacaine Injection Market Size by Region
    • 9.3.1 Asia-Pacific Ropivacaine Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Ropivacaine Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Ropivacaine Injection Market Size by Country
    • 10.3.1 South America Ropivacaine Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Ropivacaine Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Ropivacaine Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Ropivacaine Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Ropivacaine Injection Market Size by Country
    • 11.3.1 Middle East & Africa Ropivacaine Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Ropivacaine Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Ropivacaine Injection Market Drivers
  • 12.2 Ropivacaine Injection Market Restraints
  • 12.3 Ropivacaine Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Ropivacaine Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Ropivacaine Injection
  • 13.3 Ropivacaine Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Ropivacaine Injection Typical Distributors
  • 14.3 Ropivacaine Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Ropivacaine Injection market size was valued at US$ 1565 million in 2025 and is forecast to a readjusted size of US$ 2382 million by 2032 with a CAGR of 6.2% during review period.
    Ropivacaine injection is used to cause numbness or loss of feeling in patients before and during surgery or labor and delivery. It is also used to relieve acute pain. Ropivacaine is a local anesthetic and does not cause loss of consciousness.
    Anesthetics are an indispensable class of important chemical substances in modern clinical surgery. The mechanism of action is to inhibit and block the conduction of nerve impulses. It plays an important role in alleviating the pain of patients and promoting the development of surgical medicine. With the development of medicine, more attention is paid to the patient"s somatosensory, and the increase of painless surgery has promoted this market.
    This report is a detailed and comprehensive analysis for global Ropivacaine Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Ropivacaine Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ropivacaine Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ropivacaine Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Ropivacaine Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Ropivacaine Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Ropivacaine Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Akorn, Anant Pharmaceuticals, SGPharma, Nephron Pharmaceuticals, Sintetica SA, AstraZeneca, Manus Aktteva Biopharma LLP, Zhejiang Xianju Pharmaceutical Co.,Ltd, Jiangsu Nhwa Pharmaceutical Co.,Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Ropivacaine Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    2 mg/mL (0.2%)
    5 mg/mL (0.5%)
    7.5 mg/mL (0.75%)
    10 mg/mL (1%)
    Market segment by Application
    Surgical Anesthesia
    Major Nerve Block
    Acute Pain Management
    Other
    Major players covered
    Pfizer
    Akorn
    Anant Pharmaceuticals
    SGPharma
    Nephron Pharmaceuticals
    Sintetica SA
    AstraZeneca
    Manus Aktteva Biopharma LLP
    Zhejiang Xianju Pharmaceutical Co.,Ltd
    Jiangsu Nhwa Pharmaceutical Co.,Ltd.
    Yangzi River Pharmaceutical Group
    Jiangsu Hengrui Pharmaceuticals Co., Ltd.
    Jiangsu Nhwa Pharmaceutical Co.,Ltd
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Ropivacaine Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Ropivacaine Injection, with price, sales quantity, revenue, and global market share of Ropivacaine Injection from 2021 to 2026.
    Chapter 3, the Ropivacaine Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Ropivacaine Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Ropivacaine Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Ropivacaine Injection.
    Chapter 14 and 15, to describe Ropivacaine Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now